Efavirenz

Greg L. Plosker; Caroline M. Perry; Karen L. Goa

doi:10.2165/00019053-200119040-00009

Keywords

EfavirenzQuality of Life ResearchMedicinePublic healthHealth economicsFamily medicineHuman immunodeficiency virus (HIV)Antiretroviral therapyNursingViral load

Related Publications

Efavirenz

Julie Adkins , Stuart Noble

1998 Drugs 275 citations

Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti

Patrice Sévère , Marc Antoine Jean Juste , Alex Ambroise +11 more

Early initiation of antiretroviral therapy decreased the rates of death and incident tuberculosis. Access to antiretroviral therapy should be expanded to include all HIV-infecte...

2010 New England Journal of Medicine 374 citations

HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy

Steven J. Reynolds , Frederick Makumbi , Gertrude Nakigozi +5 more

HIV-1 transmission may be reduced among HIV-1 discordant couples after initiation of ART due to reductions in HIV-1 viral load and increased consistent condom use.

2010 AIDS 186 citations

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA

Charles C. J. Carpenter

1996 JAMA 487 citations

The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter

David Katzenstein , Scott M. Hammer , Michael D. Hughes +9 more

Both the risk of the progression of HIV disease and the efficacy of antiretroviral therapy are strongly associated with the plasma level of HIV RNA and with the viral phenotype....

1996 New England Journal of Medicine 483 citations

Publication Info

Year: 2001
Type: review
Volume: 19
Issue: 4
Pages: 421-436
Citations: 24
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Efavirenz

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Greg L. Plosker, 
                                
                                    Caroline M. Perry, 
                                
                                    Karen L. Goa
                                
                            (2001). 
                            Efavirenz. 
                            PharmacoEconomics
                            , 19
                            (4)
                            , 421-436.
                            https://doi.org/10.2165/00019053-200119040-00009

Identifiers

DOI: 10.2165/00019053-200119040-00009